MiniMed rises after Q4 revenue beat
03/06/2026 13:41
BUZZ-MiniMed rises after Q4 revenue beat ** Shares of diabetes care company MiniMed MMED.O rise 4.7% to $12.88 premarket
** MMED posts Q4 net sales of $837 mln, above analysts' estimates of $827.3 mln - data compiled by LSEG
** Reports 2026 sales of $3.1 bln, above analysts' estimates of $3.08 bln
** Expects organic revenue growth of about 10% for fiscal year 2027
** Analysts on an average expect 2027 revenue to be $3.4 bln
** Up to last close, stock is down 33.5% since its IPO in March
(Reporting by Siddhi Mahatole)